Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 2/3 3Phase NA 1Phase 3 1Phase 1 1

Status

Terminated 2Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Locally Advanced HER2-negative Breast Cancer 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Interventional × AC protocol × Clear all
NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
366 enrolled
Breast

Breast Neoplasms

NCT02096588 2024-07-09

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
34 enrolled 11 charts
Breast

Breast Neoplasms

NCT04248998 2023-01-18

BREAKFAST

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
30 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01329627 2014-05-21

TAME-01

Instituto do Cancer do Estado de São Paulo

Phase 2 Terminated
12 enrolled
Breast

Locally Advanced HER2-negative Breast Cancer

NCT00849472 2014-03-04

Treatment With Pazopanib for Neoadjuvant Breast Cancer

GlaxoSmithKline

Phase 2 Completed
101 enrolled 16 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡